Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort

Clinical Research in Cardiology

Volumn 104, Issue 4, 2015, Pages 351-362

  Schymik, Gerhard ^a   Tzamalis, Panagiotis ^a   Bramlage, Peter ^b   Heimeshoff, Martin ^c   Würth, Alexander ^d   Wondraschek, Rainer ^a   Gonska, Bernd Dieter ^d   Posival, Herbert ^c   Schmitt, Claus ^a   Schröfel, Holger ^c   Luik, Armin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Institute für Pharmakologie und Präventive Medizin   (Germany)

^c Clinic for Cardiac Surgery Karlsruhe   (Germany)

^d St Vincentius Hospital Karlsruhe   (Germany)

Author keywords

CoreValve; Edwards SAPIEN; Left bundle branch block; Mortality; Permanent pacemaker

Indexed keywords

ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; BUNDLE-BRANCH BLOCK; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; GERMANY; HEART CATHETERIZATION; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; BUNDLE-BRANCH BLOCK; CARDIAC CATHETERIZATION; CAUSALITY; COHORT STUDIES; FEMALE; GERMANY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84939980931     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0791-2     Document Type: Article

References (42)

1. Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
2. Diemert P, Lange P, Greif M, Seiffert M, Conradi L, Massberg S, Blankenberg S, Reichenspurner H et al (2014) Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol 103:183–190
3. Haussig S, Schuler G, Linke A (2014) Worldwide TAVI registries: what have we learned? Clin Res Cardiol 103:603–612
4. Seiffert M, Sinning JM, Meyer A, Wilde S, Conradi L, Vasa-Nicotera M, Ghanem A, Kempfert J et al (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol 103:631–640
5. Sedaghat A, Sinning JM, Vasa-Nicotera M, Ghanem A, Hammerstingl C, Grube E, Nickenig G, Werner N (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102:821–829
6. Schymik G, Heimeshoff M, Bramlage P, Wondraschek R, Suselbeck T, Gerhardus J, Luik A, Posival H et al (2014) Ruptures of the device landing zone in patients undergoing transcatheter aortic valve implantation: an analysis of TAVI Karlsruhe (TAVIK) patients. Clin Res Cardiol 103(11):912–920
7. Tang GH, Lansman SL, Cohen M, Spielvogel D, Cuomo L, Ahmad H, Dutta T (2013) Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook. Cardiol Rev 21:55–76
8. van der Boon RM, Nuis RJ, Van Mieghem NM, Jordaens L, Rodes-Cabau J, van Domburg RT, Serruys PW, Anderson RH et al (2012) New conduction abnormalities after TAVI—frequency and causes. Nat Rev Cardiol 9:454–463
9. Lim GB (2014) Valvular disease: implications of new-onset conduction abnormalities after TAVI. Nat Rev Cardiol 11:127
10. Martinez-Selles M, Bramlage P, Thoenes M, Schymik G (2014) Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol
11. Bagur R, Rodes-Cabau J, Gurvitch R, Dumont E, Velianou JL, Manazzoni J, Toggweiler S, Cheung A et al (2012) Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv 5:540–551
12. Simms AD, Hogarth AJ, Hudson EA, Worsnop VL, Blackman DJ, O’Regan DJ, Tayebjee MH (2013) Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement. Interact CardioVasc Thorac Surg 17:328–333
13. Fraccaro C, Napodano M, Tarantini G (2013) Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv 81:1217–1223
14. Tzikas A, Piazza N, Geleijnse ML, Van Mieghem N, Nuis RJ, Schultz C, van Geuns RJ, Galema TW et al (2010) Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic CoreValve system in patients with aortic stenosis. Am J Cardiol 106:255–260
15. Baan J Jr, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ et al (2010) Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 159:497–503
16. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R et al (2011) Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 107:747–754
17. Franzoni I, Latib A, Maisano F, Costopoulos C, Testa L, Figini F, Giannini F, Basavarajaiah S et al (2013) Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol 112:554–559
18. Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F et al (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126:720–728
19. Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, DeLarochelliere R, Doyle D, Igual A et al (2012) Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 60:1743–1752
20. Testa L, Latib A, De Marco F, De Carlo M, Agnifili M, Latini RA, Petronio AS, Ettori F et al (2013) Clinical impact of persistent left bundle-branch block after transcatheter aortic valve implantation with CoreValve Revalving System. Circulation 127:1300–1307
21. Houthuizen P, van der Boon RM, Urena M, Van Mieghem N, Brueren GB, Poels TT, Van Garsse LA, Rodes-Cabau J et al (2014) Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 9:1142–1150
22. Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rodes-Cabau J, Szeto WY, Jilaihawi H et al (2014) Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 35:1599–1607
23. Schymik G, Schröfel H, Schymik JS, Wondraschek R, Süselbeck T, Kiefer R, Balthasar V, Luik A et al (2012) Acute and late outcomes of Transcatheter Aortic Valve Implantation (TAVI) for the treatment of severe symptomatic aortic stenosis in patients at high- and low-surgical risk. J Interv Cardiol 25:364–374
24. Willems JL, Robles de Medina EO, Bernard R, Coumel P, Fisch C, Krikler D, Mazur NA, Meijler FL et al (1985) Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol 5:1261–1275
25. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329
26. Roten L, Wenaweser P, Delacretaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A et al (2010) Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106:1473–1480
27. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 1:310–316
28. Bjerre Thygesen J, Loh PH, Cholteesupachai J, Franzen O, Sondergaard L (2014) Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. J Invasive Cardiol 26:94–99
29. Gutierrez M, Rodes-Cabau J, Bagur R, Doyle D, DeLarochelliere R, Bergeron S, Lemieux J, Villeneuve J et al (2009) Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 158:302–308
30. Godin M, Eltchaninoff H, Furuta A, Tron C, Anselme F, Bejar K, Sanchez-Giron C, Bauer F et al (2010) Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 106:707–712
31. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N et al (2011) Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 32:2067–2074
32. Enriquez A, Barrero R, Bittner A, Frangini P, Baeza M, Millapan I, Gonzalez R, Vergara I (2013) Cardiac resynchronization therapy in patients with heart failure: a 10-year experience. Rev Med Chil 141:968–976
33. Frigerio M, Lunati M, Pasqualucci D, Vargiu S, Foti G, Pedretti S, Vittori C, Cattafi G et al (2014) Left ventricular ejection fraction overcrossing 35% after one year of cardiac resynchronization therapy predicts long term survival and freedom from sudden cardiac death: single center observational experience. Int J Cardiol 172:64–71
34. Gold MR, Leman RB, Wold N, Sturdivant JL, Yu Y (2014) The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol 25(6):624–630
35. Rickard J, Cheng A, Spragg D, Green A, Leff B, Tang W, Cantillon D, Baranowski B et al (2014) Survival in octogenarians undergoing cardiac resynchronization therapy compared to the general population. Pacing Clin Electrophysiol 37(6):740–744
36. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C (2009) Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 32(Suppl 1):S126–S130
37. Luca Botto G, Ricci RP, Benezet JM, Cosedis Nielsen J, De Roy L, Piot O, Quesada A, Quaglione R et al (2014) Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Heart Rhythm 11(6):992–1000
38. Ahmed M, Gorcsan J 3rd, Marek J, Ryo K, Haugaa K, Schwartzman DRLD (2014) Right ventricular apical pacing-induced left ventricular dyssynchrony is associated with a subsequent decline in ejection fraction. Heart Rhythm 11:602–608
39. Akerstrom F, Arias MA, Pachon M, Jimenez-Lopez J, Puchol A, Julia-Calvo J (2013) The importance of avoiding unnecessary right ventricular pacing in clinical practice. World J Cardiol 5:410–419
40. Roten L, Meier B (2014) Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv 7:137–139
41. van der Boon RM, Van Mieghem NM, Theuns DA, Nuis RJ, Nauta ST, Serruys PW, Jordaens L, van Domburg RT et al (2013) Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol 168:1269–1273
42. Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, Hancock EW, Josephson M et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 119:e235–e240